Search Through All Notices
Joint Information Center – JIC Release No. 1059
May 27, 2022, 5:50 p.m. (ChST)
363rd COVID-19-related Fatality Reported;
COVID-19 Test Results: 61 New Cases, Six Hospitalized
363rd COVID-19-related Fatality Reported
Today, the Joint Information Center was notified that Guam’s 363rd COVID-19-related fatality was pronounced dead on arrival at the Guam Regional Medical City on May 7, 2022. The patient was a 58-year-old male, unvaccinated, with underlying health conditions, who tested positive on May 7.
“Jeff, Josh, and I offer our sincerest condolences to his family,” said Governor Lou Leon Guerrero. “Today’s news of another member of our community lost is a harsh reminder that COVID-19 remains ever present. Those who suffer from cold or flu-like symptoms, especially individuals with underlying health conditions, are reminded not to wait until it’s too late. Check in with your doctor and get tested if you have symptoms.”
COVID-19 Test Results: 61 New Cases Reported
Today, DPHSS reported 61 new cases of COVID-19 from 1,466 specimens analyzed May 26, 2022. 35 of the cases reported today are through the Department of Defense. To date, there have been a total of 48,968 officially reported cases, 363 deaths, 300 cases in active isolation, and 48,305 not in active isolation.
Six Hospitalized for COVID-19
SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 4 vaccinated people hospitalized for COVID-19 compared to 20 unvaccinated people hospitalized for COVID-19. The risk of being hospitalized for COVID-19 is about 5 times higher for the unvaccinated as compared to the vaccinated. *Estimated population is based on DPHSS Immunization Program analysis of 2020 Census data. Updates are expected pending further Census 2020 data breakdown.
Second COVID-19 Booster Doses Available
Second doses of the COVID-19 booster are available to individuals ages 12 years and older who are moderately or severely immunocompromised. Eligible individuals may receive a second booster dose using an mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccine at least 4 months after the first booster dose.
Adults between the ages of 18 and 49 who are not moderately or severely immunocompromised and who received Janssen COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the Janssen booster dose. Adults ages 50 years and older could benefit from a second mRNA booster dose as they are at increased risk for severe COVID-19. Adults 50 years and older may receive a second booster dose, if it has been at least 4 months after the first booster dose.
Guam COVID-19 Vaccination Update
As of May 26, 2022, 136,665 eligible residents (5 years and older) are fully vaccinated. This total includes 14,005residents 12 – 17 years old. 8,029 residents 5 – 11 years old received their first dose of the Pfizer-BioNTech two dose series. 6,463 residents 5 – 11 years old have completed their two-dose series. 59,459 eligible residents have received their first booster shots. 5,120 eligible residents have received their second booster shots.
-###-
May 27, 2022, 5:50 p.m. (ChST)
363rd COVID-19-related Fatality Reported;
COVID-19 Test Results: 61 New Cases, Six Hospitalized
363rd COVID-19-related Fatality Reported
Today, the Joint Information Center was notified that Guam’s 363rd COVID-19-related fatality was pronounced dead on arrival at the Guam Regional Medical City on May 7, 2022. The patient was a 58-year-old male, unvaccinated, with underlying health conditions, who tested positive on May 7.
“Jeff, Josh, and I offer our sincerest condolences to his family,” said Governor Lou Leon Guerrero. “Today’s news of another member of our community lost is a harsh reminder that COVID-19 remains ever present. Those who suffer from cold or flu-like symptoms, especially individuals with underlying health conditions, are reminded not to wait until it’s too late. Check in with your doctor and get tested if you have symptoms.”
COVID-19 Test Results: 61 New Cases Reported
Today, DPHSS reported 61 new cases of COVID-19 from 1,466 specimens analyzed May 26, 2022. 35 of the cases reported today are through the Department of Defense. To date, there have been a total of 48,968 officially reported cases, 363 deaths, 300 cases in active isolation, and 48,305 not in active isolation.
Six Hospitalized for COVID-19
| CENSUS as of 5 p.m. | GMH | GRMC | USNH | TOTAL |
|---|---|---|---|---|
| COVID-19 Admission | 3 | 3 | 0 | 6 |
| Pediatric Admissions | 0 | - | - | 0 |
| ICU | 1 | 0 | 0 | 1 |
| Ventilator | 1 | 0 | 0 | 1 |
| VACCINATION STATUS | VACCINATED | UNVACCINATED | INELIGIBLE (0-4 years old) |
| Hospitalized | 5 | 1 | 0 |
| Total in Population* | 136,665 | 4,942 | 12,229 |
| Rate per 100,000 Population | 4 | 20 | 0 |
Second COVID-19 Booster Doses Available
Second doses of the COVID-19 booster are available to individuals ages 12 years and older who are moderately or severely immunocompromised. Eligible individuals may receive a second booster dose using an mRNA (Pfizer-BioNTech or Moderna) COVID-19 vaccine at least 4 months after the first booster dose.
Adults between the ages of 18 and 49 who are not moderately or severely immunocompromised and who received Janssen COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the Janssen booster dose. Adults ages 50 years and older could benefit from a second mRNA booster dose as they are at increased risk for severe COVID-19. Adults 50 years and older may receive a second booster dose, if it has been at least 4 months after the first booster dose.
|
FREE COVID-19 VACCINATION CLINICS (AGES 5 AND OVER) FIRST, SECOND AND BOOSTER SHOTS AVAILABLE - Pfizer-BioNTech, Moderna, Johnson & Johnson |
|
|
Mon. - Sat. 11 a.m. - 5 p.m. |
Agana Shopping Center (2nd Floor) - Register: tinyurl.com/vaxguam Walk-ins are welcome, but appointments will be expedited. Bring appointment confirmation and proof of identity. Last appointment is 30 minutes before closing. |
|
Mon. - Thurs. 9 a.m. - 5 p.m. Sat: 9 a.m. - 12 p.m. |
DPHSS Northern Region Community Health Center (NRCHC), Dededo Call 671-635-4418/7400 to schedule an appointment. Last appointment is 30 minutes before closing. Walk-ins welcome. Curbside vaccination available for people with disabilities. Register at tinyurl.com/covidstopswithme |
|
Mon. - Fri. 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan Call (671) 828-7604/5/7518 to schedule an appointment. Last appointment is 30 minutes before closing. Walk-ins welcome. Curbside vaccination available for people with disabilities. Register at tinyurl.com/covidstopswithme |
|
FREE COVID-19 COMMUNITY TESTING Fill out a COVID-19 Testing Patient Assessment Form ahead of time, available at dphss.guam.gov/covid-19-testing. |
|
|
Mon, Wed, Fri, & Sat: 8 a.m. - 11 a.m. |
Old Carnival Grounds, Tiyan, Barrigada COVID-19 testing will be offered by appointment through tinyurl.com/covidstopswithme. Four adults per vehicle. Bring a photo ID.Travel-related testing will not be offered. NO SYMPTOMS NEEDED TO TEST FOR COVID-19 |
|
Tuesdays and Thursdays: 9 a.m. - 12 p.m. |
DPHSS Southern Region Community Health Center (SRCHC), Inalåhan By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Travel-related testing not offered. Call (671) 828-7604/5/7518. Register at tinyurl.com/covidstopswithme |
|
Monday through Saturday: 9 a.m. - 12 p.m. |
DPHSS Northern Region Community Health Center (NRCHC), Dededo By appointment only for individuals with COVID-like symptoms. Four adults per vehicle. Bring a photo ID. Call (671) 635-7525/6 to schedule an appointment. |
Guam COVID-19 Vaccination Update
As of May 26, 2022, 136,665 eligible residents (5 years and older) are fully vaccinated. This total includes 14,005residents 12 – 17 years old. 8,029 residents 5 – 11 years old received their first dose of the Pfizer-BioNTech two dose series. 6,463 residents 5 – 11 years old have completed their two-dose series. 59,459 eligible residents have received their first booster shots. 5,120 eligible residents have received their second booster shots.
-###-
